BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 35084988)

  • 1. What Has the Undiagnosed Diseases Network Taught Us About the Clinical Applications of Genomic Testing?
    Murdock DR; Rosenfeld JA; Lee B
    Annu Rev Med; 2022 Jan; 73():575-585. PubMed ID: 35084988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limitations of exome sequencing in detecting rare and undiagnosed diseases.
    Burdick KJ; Cogan JD; Rives LC; Robertson AK; Koziura ME; Brokamp E; Duncan L; Hannig V; Pfotenhauer J; Vanzo R; Paul MS; Bican A; Morgan T; Duis J; Newman JH; Hamid R; Phillips JA;
    Am J Med Genet A; 2020 Jun; 182(6):1400-1406. PubMed ID: 32190976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical sites of the Undiagnosed Diseases Network: unique contributions to genomic medicine and science.
    Schoch K; Esteves C; Bican A; Spillmann R; Cope H; McConkie-Rosell A; Walley N; Fernandez L; Kohler JN; Bonner D; Reuter C; Stong N; Mulvihill JJ; Novacic D; Wolfe L; Abdelbaki A; Toro C; Tifft C; Malicdan M; Gahl W; Liu P; Newman J; Goldstein DB; Hom J; Sampson J; Wheeler MT; ; Cogan J; Bernstein JA; Adams DR; McCray AT; Shashi V
    Genet Med; 2021 Feb; 23(2):259-271. PubMed ID: 33093671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yield of whole exome sequencing in undiagnosed patients facing insurance coverage barriers to genetic testing.
    Reuter CM; Kohler JN; Bonner D; Zastrow D; Fernandez L; Dries A; Marwaha S; Davidson J; Brokamp E; Herzog M; Hong J; Macnamara E; Rosenfeld JA; Schoch K; Spillmann R; ; Loscalzo J; Krier J; Stoler J; Sweetser D; Palmer CGS; Phillips JA; Shashi V; Adams DA; Yang Y; Ashley EA; Fisher PG; Mulvihill JJ; Bernstein JA; Wheeler MT
    J Genet Couns; 2019 Dec; 28(6):1107-1118. PubMed ID: 31478310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A guide for the diagnosis of rare and undiagnosed disease: beyond the exome.
    Marwaha S; Knowles JW; Ashley EA
    Genome Med; 2022 Feb; 14(1):23. PubMed ID: 35220969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine Learning of Patient Characteristics to Predict Admission Outcomes in the Undiagnosed Diseases Network.
    Amiri H; Kohane IS;
    JAMA Netw Open; 2021 Feb; 4(2):e2036220. PubMed ID: 33630084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A toolkit for genetics providers in follow-up of patients with non-diagnostic exome sequencing.
    Zastrow DB; Kohler JN; Bonner D; Reuter CM; Fernandez L; Grove ME; Fisk DG; ; Yang Y; Eng CM; Ward PA; Bick D; Worthey EA; Fisher PG; Ashley EA; Bernstein JA; Wheeler MT
    J Genet Couns; 2019 Apr; 28(2):213-228. PubMed ID: 30964584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and discovery: Insights from the NIH Undiagnosed Diseases Program.
    Montano C; Cassini T; Ziegler SG; Boehm M; Nicoli ER; Mindell JA; Soldatos AG; Manoli I; Wolfe L; Macnamara EF; Malicdan MCV; Adams DR; Tifft CJ; Toro C; Gahl WA
    J Inherit Metab Dis; 2022 Sep; 45(5):907-918. PubMed ID: 35490291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons learnt from multifaceted diagnostic approaches to the first 150 families in Victoria's Undiagnosed Diseases Program.
    Cloney T; Gallacher L; Pais LS; Tan NB; Yeung A; Stark Z; Brown NJ; McGillivray G; Delatycki MB; de Silva MG; Downie L; Stutterd CA; Elliott J; Compton AG; Lovgren A; Oertel R; Francis D; Bell KM; Sadedin S; Lim SC; Helman G; Simons C; Macarthur DG; Thorburn DR; O'Donnell-Luria AH; Christodoulou J; White SM; Tan TY
    J Med Genet; 2022 Aug; 59(8):748-758. PubMed ID: 34740920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exome/Genome Sequencing in Undiagnosed Syndromes.
    Sullivan JA; Schoch K; Spillmann RC; Shashi V
    Annu Rev Med; 2023 Jan; 74():489-502. PubMed ID: 36706750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case for genome sequencing in infants and children with rare, undiagnosed or genetic diseases.
    Bick D; Jones M; Taylor SL; Taft RJ; Belmont J
    J Med Genet; 2019 Dec; 56(12):783-791. PubMed ID: 31023718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model Organisms Facilitate Rare Disease Diagnosis and Therapeutic Research.
    Wangler MF; Yamamoto S; Chao HT; Posey JE; Westerfield M; Postlethwait J; ; Hieter P; Boycott KM; Campeau PM; Bellen HJ
    Genetics; 2017 Sep; 207(1):9-27. PubMed ID: 28874452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic utility of transcriptome sequencing for rare Mendelian diseases.
    Lee H; Huang AY; Wang LK; Yoon AJ; Renteria G; Eskin A; Signer RH; Dorrani N; Nieves-Rodriguez S; Wan J; Douine ED; Woods JD; Dell'Angelica EC; Fogel BL; Martin MG; Butte MJ; Parker NH; Wang RT; Shieh PB; Wong DA; Gallant N; Singh KE; Tavyev Asher YJ; Sinsheimer JS; Krakow D; Loo SK; Allard P; Papp JC; ; Palmer CGS; Martinez-Agosto JA; Nelson SF
    Genet Med; 2020 Mar; 22(3):490-499. PubMed ID: 31607746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International Undiagnosed Diseases Programs (UDPs): components and outcomes.
    Curic E; Ewans L; Pysar R; Taylan F; Botto LD; Nordgren A; Gahl W; Palmer EE
    Orphanet J Rare Dis; 2023 Nov; 18(1):348. PubMed ID: 37946247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Genetic Diagnosis on Patients with Previously Undiagnosed Disease.
    Splinter K; Adams DR; Bacino CA; Bellen HJ; Bernstein JA; Cheatle-Jarvela AM; Eng CM; Esteves C; Gahl WA; Hamid R; Jacob HJ; Kikani B; Koeller DM; Kohane IS; Lee BH; Loscalzo J; Luo X; McCray AT; Metz TO; Mulvihill JJ; Nelson SF; Palmer CGS; Phillips JA; Pick L; Postlethwait JH; Reuter C; Shashi V; Sweetser DA; Tifft CJ; Walley NM; Wangler MF; Westerfield M; Wheeler MT; Wise AL; Worthey EA; Yamamoto S; Ashley EA;
    N Engl J Med; 2018 Nov; 379(22):2131-2139. PubMed ID: 30304647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic medicine for undiagnosed diseases.
    Wise AL; Manolio TA; Mensah GA; Peterson JF; Roden DM; Tamburro C; Williams MS; Green ED
    Lancet; 2019 Aug; 394(10197):533-540. PubMed ID: 31395441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exome and genome sequencing in a heterogeneous population of patients with rare disease: Identifying predictors of a diagnosis.
    Pucel J; Briere LC; Reuter C; Gochyyev P; ; LeBlanc K
    Genet Med; 2024 Jun; 26(6):101115. PubMed ID: 38436216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Whole exome sequencing and whole genome sequencing in undiagnosed disease: of value for certain patient populations].
    Linthorst GE; Hollak CEM
    Ned Tijdschr Geneeskd; 2019 May; 163():. PubMed ID: 31120221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network.
    Spillmann RC; Tan QK; Reuter C; Schoch K; ; Kohler J; Bonner D; Zastrow D; Alkelai A; Baugh E; Cope H; Marwaha S; Wheeler MT; Bernstein JA; Shashi V;
    Genet Med; 2023 Apr; 25(4):100353. PubMed ID: 36481303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does genomic sequencing early in the diagnostic trajectory make a difference? A follow-up study of clinical outcomes and cost-effectiveness.
    Stark Z; Schofield D; Martyn M; Rynehart L; Shrestha R; Alam K; Lunke S; Tan TY; Gaff CL; White SM
    Genet Med; 2019 Jan; 21(1):173-180. PubMed ID: 29765138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.